Hepatitis E VirClia – fully automated solution for Hepatitis E serology

Fast | Precise | Automated

Elevate your diagnostic precision with the first commercial HEV avidity test, ensuring reliable confirmation of acute infections. Vircell’s comprehensive Hepatitis E solution including IgM, IgG, and IgG avidity assays delivers fast, precise, and automated results for confident detection.

A fully automated solution for Hepatitis E serology

• Hepatitis E virus (HEV) is the most common cause of acute hepatitis in the world¹.
• Every year, there are an estimated 20 million HEV infections worldwide, leading to an estimated 3.3 million symptomatic cases of hepatitis E².
• WHO estimates that hepatitis E caused approximately 44,000 deaths in 2015 (accounting for 3.3% of the mortality due to viral hepatitis)².
• The virus is transmitted via the fecal-oral route, principally via contaminated water.
• Hepatitis E is found worldwide, but the disease is most common in East and South Asia.

Vircell offers a fully automated solution for Hepatitis E serology on the VirClia instruments:

• Hepatitis E IgG Avidity Monotest
• Hepatitis E IgG Monotest
• Hepatitis E IgM Monotest

The Vircell Hepatitis E VirClia IgM, IgG, and IgG avidity assays offer several advantages for detecting Hepatitis E virus (HEV) antibodies:

• Comprehensive detection – Covers IgM for acute infections, IgG for past exposure, and IgG avidity to distinguish recent from past infections.
• Fast results – Provides results within 1 hour, making it ideal for urgent samples.
• Monotest format – Each test includes a calibrator and negative control, ensuring accurate validation.
• Automated and simple protocol – Works with primary sample tubes, reducing manual handling.
• High sensitivity and specificity – Delivers reliable detection of HEV antibodies.
• First commercial avidity test – Helps confirm acute Hepatitis E infections, improving diagnostic accuracy.
• No need to batch samples

A study in Madrid, Spain confirmed the Vircell Hepatitis E method is a reliable serological method for the screening of acute infection in HEV clinical specimens.  View the poster here.

References:

1. https://www.who.int/news-room/fact-sheets/detail/hepatitis-E

2. https://aho.org/fact-sheets/hepatitis-e-fact-sheet/

THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.

Go Back